Experts see better glucose rates using dapagliflozin as add-on

06/30/2011 | Medscape (free registration)

Adding dapagliflozin to metformin therapy enhanced the treatment's efficacy in lowering blood glucose levels in patients newly diagnosed with type 2 diabetes, experts reported at the annual meeting of the American Diabetes Association. One study found that about 52% of patients on metformin-dapagliflozin treatment had hemoglobin A1c levels of 7% or less compared to 34.6% and 22.5% in those who only took either metformin or dapagliflozin, respectively. A second study had similar results.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD